Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia

BACKGROUND: Tobacco smoking is the leading preventable cause of morbidity and mortality in Australia and other developed countries. Of the pharmacological aids that are available for smoking cessation, bupropion (Zyban SR) is eligible for public reimbursement on the Australian Pharmaceutical Benefit...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bertram, Melanie Y, Lim, Stephen S, Wallace, Angela L, Vos, Theo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Group 2007
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2598534/
https://ncbi.nlm.nih.gov/pubmed/17652241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/tc.2006.017657
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak